Literature DB >> 31825485

Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.

Victoria Higgins1,2, Shervin Asgari1, Jill K Hamilton3,4, Anna Wolska5, Alan T Remaley5, Bolette Hartmann6,7, Jens J Holst6,7, Khosrow Adeli1,2.   

Abstract

BACKGROUND: With increased rates of obesity and insulin resistance in youth, development of postprandial dyslipidemia, an important cardiovascular disease risk factor, is a concern. Glucagon-like peptides (ie, GLP-1 and GLP-2) and bile acids have been shown to regulate dietary fat absorption and postprandial lipids in animal models and humans. We hypothesize that the physiological response of GLPs and bile acids to dietary fat ingestion is impaired in adolescents with obesity and this associates with marked postprandial dyslipidemia and insulin resistance.
METHODS: In this cross-sectional study, normal weight adolescents and adolescents with obesity underwent a 6-hour oral fat tolerance test. The postprandial lipoprotein phenotype profile was determined using various assays, including nuclear magnetic resonance spectroscopy, to characterize lipoprotein particle number, size, lipid content, and apolipoproteins. GLP-1 and GLP-2 were quantified by electrochemiluminescent immunoassays. Total bile acids were measured by an automated enzymatic cycling colorimetric method and the bile acid profile by mass spectrometry.
RESULTS: Adolescents with obesity exhibited fasting and postprandial dyslipidemia, particularly augmented postprandial excursion of large triglyceride-rich lipoproteins. Postprandial GLPs were reduced and inversely correlated with postprandial dyslipidemia and insulin resistance. Postprandial bile acids were also diminished, particularly lithocholic acid, a potent stimulator of GLP-1 secretion.
CONCLUSION: Blunted postprandial GLP and bile acid response to dietary fat ingestion strongly associates with marked postprandial dyslipidemia. Further investigation is needed to assess their potential utility as early biomarkers for postprandial dyslipidemia in adolescents with obesity. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Glucagon-Like Peptide 1; bile acids; dyslipidemia; insulin resistance; pediatric obesity

Mesh:

Substances:

Year:  2020        PMID: 31825485      PMCID: PMC7065844          DOI: 10.1210/clinem/dgz261

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

1.  Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.

Authors:  Wook Ha Park; Youngmi Kim Pak
Journal:  Exp Mol Med       Date:  2011-10-31       Impact factor: 8.718

2.  Modification and Validation of the Triglyceride-to-HDL Cholesterol Ratio as a Surrogate of Insulin Sensitivity in White Juveniles and Adults without Diabetes Mellitus: The Single Point Insulin Sensitivity Estimator (SPISE).

Authors:  Katharina Paulmichl; Mensud Hatunic; Kurt Højlund; Aleksandra Jotic; Michael Krebs; Asimina Mitrakou; Francesca Porcellati; Andrea Tura; Peter Bergsten; Anders Forslund; Hannes Manell; Kurt Widhalm; Daniel Weghuber; Christian-Heinz Anderwald
Journal:  Clin Chem       Date:  2016-07-28       Impact factor: 8.327

3.  Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.

Authors:  Atsuhiko Ichimura; Akira Hirasawa; Odile Poulain-Godefroy; Amélie Bonnefond; Takafumi Hara; Loïc Yengo; Ikuo Kimura; Audrey Leloire; Ning Liu; Keiko Iida; Hélène Choquet; Philippe Besnard; Cécile Lecoeur; Sidonie Vivequin; Kumiko Ayukawa; Masato Takeuchi; Kentaro Ozawa; Maithé Tauber; Claudio Maffeis; Anita Morandi; Raffaella Buzzetti; Paul Elliott; Anneli Pouta; Marjo-Riitta Jarvelin; Antje Körner; Wieland Kiess; Marie Pigeyre; Roberto Caiazzo; Wim Van Hul; Luc Van Gaal; Fritz Horber; Beverley Balkau; Claire Lévy-Marchal; Konstantinos Rouskas; Anastasia Kouvatsi; Johannes Hebebrand; Anke Hinney; Andre Scherag; François Pattou; David Meyre; Taka-aki Koshimizu; Isabelle Wolowczuk; Gozoh Tsujimoto; Philippe Froguel
Journal:  Nature       Date:  2012-02-19       Impact factor: 49.962

4.  Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.

Authors:  Achint Kaur; Jay V Patankar; Willeke de Haan; Piers Ruddle; Nadeeja Wijesekara; Albert K Groen; C Bruce Verchere; Roshni R Singaraja; Michael R Hayden
Journal:  Diabetes       Date:  2014-10-22       Impact factor: 9.461

Review 5.  Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement.

Authors:  Genovefa D Kolovou; Dimitri P Mikhailidis; Jan Kovar; Dennis Lairon; Børge G Nordestgaard; Teik Chye Ooi; Pablo Perez-Martinez; Helen Bilianou; Katherine Anagnostopoulou; George Panotopoulos
Journal:  Curr Vasc Pharmacol       Date:  2011-05       Impact factor: 2.719

6.  The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.

Authors:  J Hsieh; C Longuet; C L Baker; B Qin; L M Federico; D J Drucker; K Adeli
Journal:  Diabetologia       Date:  2009-12-03       Impact factor: 10.122

7.  Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.

Authors:  Jutta Keller; Michael E Trautmann; Harry Haber; Lai San Tham; Tamsin Hunt; Kenneth Mace; Helle Linnebjerg
Journal:  Regul Pept       Date:  2012-09-06

8.  Effect of obesity on bioelectrical impedance.

Authors:  D S Gray; G A Bray; N Gemayel; K Kaplan
Journal:  Am J Clin Nutr       Date:  1989-08       Impact factor: 7.045

9.  Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.

Authors:  Donna F Vine; Ye Wang; Mary M Jetha; Geoff D Ball; Spencer D Proctor
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

10.  Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.

Authors:  Bernardo Yusta; Dianne Matthews; Grace B Flock; John R Ussher; Brigitte Lavoie; Gary M Mawe; Daniel J Drucker
Journal:  Mol Metab       Date:  2017-03-31       Impact factor: 7.422

View more
  3 in total

1.  Plasma Metabolic Signatures of Healthy Overweight Subjects Challenged With an Oral Glucose Tolerance Test.

Authors:  Jarlei Fiamoncini; Carlos M Donado-Pestana; Graziela Biude Silva Duarte; Milena Rundle; Elizabeth Louise Thomas; Yoana Kiselova-Kaneva; Thomas E Gundersen; Diana Bunzel; Jean-Pierre Trezzi; Sabine E Kulling; Karsten Hiller; Denise Sonntag; Diana Ivanova; Lorraine Brennan; Suzan Wopereis; Ben van Ommen; Gary Frost; Jimmy Bell; Christian A Drevon; Hannelore Daniel
Journal:  Front Nutr       Date:  2022-06-14

2.  Paediatric obesity: a systematic review and pathway mapping of metabolic alterations underlying early disease processes.

Authors:  Margot De Spiegeleer; Ellen De Paepe; Lieven Van Meulebroek; Inge Gies; Jean De Schepper; Lynn Vanhaecke
Journal:  Mol Med       Date:  2021-11-06       Impact factor: 6.354

Review 3.  Roles of gut microbiota and metabolites in overweight and obesity of children.

Authors:  Shengan Zhang; Yanqi Dang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.